Literature DB >> 10482056

Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens.

H J Marttila1, H Soini, E Vyshnevskaya, B I Vyshnevskiy, T F Otten, A V Vasilyef, M K Viljanen.   

Abstract

The sensitivity of a PCR-based line probe assay (Inno-LiPA Rif. TB Assay; Innogenetics NV Zwijndrecht, Belgium) was studied by using nested-PCR technique. A total of 75 specimens, representing various body locations from 70 suspected tuberculosis patients were obtained. LiPA yielded 30 Mycobacterium tuberculosis complex positive results (sensitivity 58.8%, compared with final diagnoses) whereas culture for M. tuberculosis was positive in 18 specimens (sensitivity 35.3%). Genotypic rifampin resistance testing by LiPA showed that 7 specimens contained rpoB mutations associated with RMP resistance, and sequencing data of the rpoB gene and LiPA patterns agreed in 29 of 30 M. tuberculosis positive specimens (96.7%). This indicates reliable performance, which makes the test suitable for the rapid determination of resistance to rifampin directly in clinical samples. However, the best results are obtained if LiPA is combined with conventional staining and culture methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482056     DOI: 10.1080/00365549950163563

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Authors:  Z Bártfai; A Somoskövi; C Ködmön; N Szabó; E Puskás; L Kosztolányi; E Faragó; J Mester; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 2.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 3.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.

Authors:  Akos Somoskovi; Qunfeng Song; Judit Mester; Charise Tanner; Yvonne M Hale; Linda M Parsons; Max Salfinger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.

Authors:  Mercedes Marín; Darío García de Viedma; María Jesús Ruíz-Serrano; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Johanna Mäkinen; Harri J Marttila; Merja Marjamäki; Matti K Viljanen; Hanna Soini
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.

Authors:  Jun-Ichiro Sekiguchi; Tomohiko Nakamura; Tohru Miyoshi-Akiyama; Fumiko Kirikae; Intetsu Kobayashi; Ewa Augustynowicz-Kopec; Zofia Zwolska; Koji Morita; Toshinori Suetake; Hiroshi Yoshida; Seiya Kato; Toru Mori; Teruo Kirikae
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

8.  Multidrug-resistant tuberculosis detection, Latvia.

Authors:  Girts Skenders; Alicia M Fry; Inga Prokopovica; Silvija Greckoseja; Lonija Broka; Beverly Metchock; Timothy H Holtz; Charles D Wells; Vaira Leimane
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

9.  Mycobacterium tuberculosis and rifampin resistance, United Kingdom.

Authors:  I-Ching Sam; Francis Drobniewski; Philip More; Melanie Kemp; Timothy Brown
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

Review 10.  PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings.

Authors:  Samuel Yang; Richard E Rothman
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.